Publication | Closed Access

Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease

Percutaneous Coronary InterventionHemodialysisUrologyCardiovascular DiseaseKidney FailureChronic Kidney DiseaseLumen-apposing Metal StentLong-term BenefitsMedicineAtherosclerosisNephrologyBare-metal Stents